Results 301 to 310 of about 116,027 (330)
Some of the next articles are maybe not open access.

Spinal Surgery in Spinal Muscular Atrophy

Journal of Pediatric Orthopaedics, 1985
Fifteen patients with surgical treatment of spinal muscular atrophy were reviewed. The curve pattern was thoracic in 3, thoracolumbar in 11, and double thoracic and thoracolumbar in 1. Follow-up averaged 31 months. Eleven patients underwent posterior spinal fusion with Harrington instrumentation, with segmental wiring in four, and two had Luque ...
Y H, Daher   +3 more
openaire   +2 more sources

Spinal Muscular Atrophy

Seminars in Neurology, 1998
The history of the spinal muscular atrophies (SMA) began in the 1890s with Guido Werdnig and Johann Hoffmann. Together, their papers present a rather complete picture of the clinical and pathologic aspects of infantile SMA: onset during the first year of life, occurrence in siblings with normal parents, progressive floppiness and weakness, hand tremor,
openaire   +2 more sources

Spinal Muscular Atrophy Diagnostics

Journal of Child Neurology, 2007
Spinal muscular atrophy is a common autosomal recessive neuromuscular disorder caused by mutations in the survival motor neuron gene ( SMN), which exists in 2 nearly identical copies ( SMN1 and SMN2). Exon 7 of SMN1 is homozygously absent in about 95% of spinal muscular atrophy patients, whereas the loss of SMN2 does not cause spinal muscular atrophy.
openaire   +2 more sources

Spinal Muscular Atrophy

2017
Spinal muscular atrophies (SMA) result in progressive degeneration of the anterior horn cells. Most patients present in infancy and childhood but later presentations are known. The condition is inexorably progressive and reduces quality and span of life. Survival motor neuron gene abnormalities are most common, but other genetic abnormalities have been
Satish V. Khadilkar   +2 more
openaire   +1 more source

Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial.

Lancet Neurology, 2022
E. Mercuri   +317 more
semanticscholar   +1 more source

Spinal muscular atrophy

International Journal of Obstetric Anesthesia, 2003
openaire   +3 more sources

Risdiplam-Treated Infants with Type 1 Spinal Muscular Atrophy versus Historical Controls

New England Journal of Medicine, 2021
Riccardo Masson   +2 more
exaly  

Home - About - Disclaimer - Privacy